MCap: $119.8B 24h Vol: $16.7B BTC Dominance: 52.52% Coins: 2116 ICOs: 1090
About Xeophin | XERA ?

Xeophin has devised a funding pathway to develop the XeRA-1 Therapeutic for Rheumatoid Arthritis, however this offering represents much more than stake in a promising pharmaceutical. Xeophins’ unique approach to Biotech funding can change the paradigm of how medicine is financed. Xeophin is tokenizing 50% of the future royalties generated by XeRA-1, allowing its’ token holders to fund, and benefit from its’ success. Our mission is to take our core technologies and drive them through our six step process. The outcome being a transaction-ready and IP protected technology portfolio, tokenized. From then on, Xeophin will undertake commercialization activities to achieve a significant royalty deal, delivering value to our XeRA-1 Token holders. Being backed by a physical asset, the XeRA-1 Arthritis Therapeutic, the XERA1 token can increase in value as milestones are hit on the road to commercialization. Once live, token holders will yield cash royalty payments, commensurate to XeRA-1s’ earnings.

Crowdsale
Start : 20 Aug, 2018
End : 22 Feb, 2019
Running & End in :
Xeophin Company Details
Registerd Company Name: XEOPHIN PTY LTD
Registerd Country (AU)
Team Member 7 Team Members
Xeophin Crowdsale Details.
Status | End in 32 Days
Registration Required : Yes! Registration Required.

Registration open 20 August, 2018 | Register Now

KYC Required : No! KYC Not Required.
ICO Start Date 20 August, 2018
ICO End Date 22 February, 2019

Blockchain

Ethereum ERC20

Soft Cap

Hard Cap

Total Supply

Price in ICO

1 XERA = 0.50 USD 0.0000 USD

Token for sale

345,450,000
Currencies Accepted

The following currencies will be accepted during the crowdsale:

Countries Not Allowed

The following countries are not allowed to participate in the crowdsale:

Add a project to our ICO Junction 1090 other projects are already listed
// Start : ICO Bonus Data // End : ICO Bonus Data // Start : ICO Distribution // End : ICO Distribution